Tax Manager
Amgen
Tax Manager
Amgen
Makes biotech medicines for serious illnesses
The Tax Manager – U.S. Direct – Tax Reporting manages a team of six Tax Associates supporting U.S. tax compliance and reporting within the India Global Capability Center (GCC). The Manager oversees day-to-day work allocation, deliverable quality, timelines, and team development across assigned U.S. federal, international, and state and local tax workstreams.
The Manager reports to the India-based Senior Manager and partners with them on team management, operating priorities, and performance. Working with the Senior Manager and U.S.-based tax stakeholders, the Manager helps ensure accurate and timely execution of tax deliverables, provides technical guidance to the team, raises issues promptly, and identifies opportunities to improve processes and controls.
The Tax Manager – U.S. Direct – Tax Reporting will be responsible for the following activities, among others:
Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.
Explore more opportunities at Amgen